Douglas W. Pagan, Chief Financial Officer at Paratek Pharmaceuticals, Inc. (PRTK), sold 15,158 shares at $9.82 ($149K) on 2018-10-03, disclosed to the SEC on 2018-10-04.
Open-market sale of $149k PRTK by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.82 | 7,579 | $74K | 50.0% |
| 2 | $9.82 | 7,579 | $74K | 50.0% |
| Total | $9.82 avg | 15,158 | $149K | 100% |
| Filing → |
| PRTK | SELL | 2018-10-16 | $25K | — | Filing → |
| PRTK | SELL | 2018-04-10 | $133K | — | Filing → |
| PRTK | SELL | 2018-02-07 | $463K | — | Filing → |